2025 United States Biopreservation Market Revenue Opportunities Report
Description
The 2025 United States Biopreservation Market Revenue Opportunities Report features 1) market size data for the region or country, 2) annual market growth rates, 3) the market's impact on related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing, 4) Total Addressable Market (TOM) for the four largest market players, 5) Serviceable Addressable Market (SAM), and 6) Serviceable Obtainable Market (SOM)(Wharry Sharpe Research)
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Biopreservation Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the U.S. biopreservation market are Thermo Fisher Scientific Inc., Merck KGaA, Azenta US, Inc., and BioLife Solutions Inc. Thermo Fisher, a U.S.-based leader, offers extensive biopreservation equipment and consumables, including advanced ultra-low temperature freezers widely used in biobanking and healthcare. Merck KGaA provides integrated biopreservation solutions spanning pharmaceuticals and regenerative medicine, with recent expansions enhancing mRNA development and manufacturing capabilities. Azenta, known for providing biobanking, sample management, and logistics solutions, focuses on integrating end-to-end services. BioLife Solutions specializes in cell therapy preservation media and technology, supporting next-generation cell-based therapies.
These companies drive market growth through innovation and strategic expansions. Thermo Fisher continually upgrades its product portfolio for better performance and efficiency, Merck expanded its contract development and manufacturing for novel therapies, and Azenta emphasizes comprehensive bio-sample management services. BioLife Solutions secures leadership via specialty media and licensed formulations that improve cell viability during storage and transport. The U.S. market is highly competitive and rapidly growing, with an estimated value surpassing USD 2 billion in 2024 and projected to reach over USD 23 billion by 2033, driven by regenerative medicine, biobanking, and personalized therapies demand.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the Biopreservation Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the U.S. biopreservation market are Thermo Fisher Scientific Inc., Merck KGaA, Azenta US, Inc., and BioLife Solutions Inc. Thermo Fisher, a U.S.-based leader, offers extensive biopreservation equipment and consumables, including advanced ultra-low temperature freezers widely used in biobanking and healthcare. Merck KGaA provides integrated biopreservation solutions spanning pharmaceuticals and regenerative medicine, with recent expansions enhancing mRNA development and manufacturing capabilities. Azenta, known for providing biobanking, sample management, and logistics solutions, focuses on integrating end-to-end services. BioLife Solutions specializes in cell therapy preservation media and technology, supporting next-generation cell-based therapies.
These companies drive market growth through innovation and strategic expansions. Thermo Fisher continually upgrades its product portfolio for better performance and efficiency, Merck expanded its contract development and manufacturing for novel therapies, and Azenta emphasizes comprehensive bio-sample management services. BioLife Solutions secures leadership via specialty media and licensed formulations that improve cell viability during storage and transport. The U.S. market is highly competitive and rapidly growing, with an estimated value surpassing USD 2 billion in 2024 and projected to reach over USD 23 billion by 2033, driven by regenerative medicine, biobanking, and personalized therapies demand.
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
Table of Contents
51 Pages
- A. Definitions
- A1. Market Definition
- A2. Market Segmentation
- A3. Industry Opportunities-Industry1
- A4. Industry Opportunities-Industry2
- A5. Industry Opportunities-Industry3
- B. Total Addressable Market (TAM)
- B1. TAM-Player 1/4
- B2. TAM-Player 2/4
- B3. TAM-Player 3/4
- B4. TAM-Player 4/4
- C. Serviceable Addressable Market (SAM)
- C1. SAM-Player 1/4
- C2. SAM-Player 2/4
- C3. SAM-Player 3/4
- C4. SAM-Player 4/4
- D. Serviceable Obtainable Market (SOM)
- D1. SOM-Player 1/4
- D2. SOM-Player 2/4
- D3. SOM-Player 3/4
- D4. SOM-Player 4/4
- E. Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
